Compound Detail
CHEMBL5571243
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](c2cc(N3CCN(Cc4ccc(-c5c6ncn(CC7(O)CCN(C(=O)C[C@@H](C)c8ccccc8)CC7)c(=O)c6nn5C)cc4)CC3)no2)C(C)C)cc1
Basic Information
| ChEMBL ID | CHEMBL5571243 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZCAILYLCWKWLIC-APKAJERZSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
1064.3
MW (Da)
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 9.3
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| RS4-11 | IC50 | = | 0.5 | nM | 9.3 | Antiproliferative activity against human RS4-11 cells with wild type p53 assesse... | 39028938 |
| REH | IC50 | = | 8.3 | nM | 8.08 | Antiproliferative activity against human REH cells with wild type p53 assessed a... | 39028938 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 39028938 | 10.1021/acs.jmedchem.4c01134 | RS4-11 | 24 |
| 39028938 | 10.1021/acs.jmedchem.4c01134 | von Hippel-Lindau disease tumor suppressor/Ubiquitin carboxyl-terminal hydrolase 7 | 14 |
| 39028938 | 10.1021/acs.jmedchem.4c01134 | Unchecked | 2 |
| 39028938 | 10.1021/acs.jmedchem.4c01134 | ADMET | 2 |
| 39028938 | 10.1021/acs.jmedchem.4c01134 | REH | 1 |
Data from ChEMBL 36 via Core Engine